Renoprotective effect of oral rehydration solution III in exertional heatstroke rats

Yu-Fang Lin, Yanning ZhangRenal 2019 · DOI

TL;DR

Exertional heatstroke (EHS) can lead to acute kidney injury (AKI). This study investigated whether oral rehydration solution III (ORS III), commonly used for gastroenteritis, could protect against EHS-induced kidney damage in rats. The findings suggest that ORS III pretreatment can indeed alleviate kidney injury in EHS rats, offering a potential preventative strategy.

What Problem Does This Paper Address?

Exertional heatstroke (EHS) is a serious condition, particularly for athletes and soldiers, characterized by a rapid rise in core body temperature and central nervous system dysfunction. A significant and often life-threatening complication of EHS is acute kidney injury (AKI). While treatments like cooling and hydration exist, they are not always satisfactory, and research into preventative measures for EHS-related AKI is limited. Traditional biomarkers for kidney injury, such as serum creatinine (SCr) and blood urea nitrogen (BUN), are often slow to detect damage, especially in the early stages. This study aims to address this gap by exploring the renoprotective potential of Oral Rehydration Solution III (ORS III), a WHO-recommended rehydration agent, in a rat model of EHS and to evaluate its efficacy using both traditional and novel kidney injury biomarkers.

Methods

The researchers employed a rat model to simulate exertional heatstroke. Male Sprague-Dawley rats were randomly assigned to four groups: Control, EHS (exposed to heat and exercise), EHS + Water (pretreated with water), and EHS + ORS III (pretreated with ORS III).

Key methodological aspects include:

  • EHS Induction: Rats were trained on a treadmill and then subjected to forced running in a heated environment until their core temperature reached 40.5°C, indicative of heatstroke.
  • Pretreatment: 30 minutes before the heat stress protocol, rats in the EHS + Water group received plain water, while the EHS + ORS III group received ORS III solution.
  • Biomarker Analysis: Blood samples were collected to measure serum creatinine (SCr), blood urea nitrogen (BUN), and neutrophil gelatinase-associated lipocalin (NGAL). NGAL was highlighted as a novel, more sensitive biomarker for early kidney injury.
  • Histological Examination: Kidney tissues were analyzed using light microscopy to assess structural damage.
  • Statistical Analysis: Standard statistical methods, including ANOVA and Kruskal-Wallis tests, were used to compare data between groups.

Datasets

Not discussed in the paper. The study utilized laboratory animals (rats) as the experimental subjects.

Key Insights and Ideas

  • ORS III as a Protective Agent: The most significant insight is that pretreatment with ORS III appears to offer a renoprotective effect against EHS-induced kidney injury in rats.
  • NGAL's Superiority: Neutrophil gelatinase-associated lipocalin (NGAL) emerged as a more sensitive biomarker for detecting early kidney injury in EHS compared to traditional markers like SCr and BUN. This highlights the potential of NGAL in clinical settings for early diagnosis and intervention.
  • Tubular vs. Glomerular Injury: The study observed that EHS primarily affects renal tubules, with less prominent glomerular damage. This specificity in injury location is important for understanding the pathophysiology of EHS-induced AKI.
  • Water Alone Insufficient: Plain water pretreatment did not show a significant benefit in preventing kidney injury, suggesting that electrolyte balance and specific components of ORS III might be crucial. This aligns with recommendations for athletes to consume electrolyte-containing fluids during prolonged exercise.

Key Results

  • NGAL Levels: Rats in the EHS group showed significantly higher NGAL levels compared to the control group. Pretreatment with ORS III significantly reduced NGAL levels compared to the EHS group, although the difference between EHS + Water and EHS groups was not significant.
  • SCr and BUN: While BUN levels were elevated in the EHS group compared to controls, SCr and BUN did not show significant differences between the EHS group and the ORS III or water-treated groups, underscoring NGAL's sensitivity.
  • Histopathology: Histological examination revealed milder tubular injury in the EHS + ORS III group compared to the EHS and EHS + Water groups, which showed more severe degeneration and sloughing of tubular epithelium.
  • Exercise Performance: Rats pretreated with ORS III exhibited a longer exercise time before fatigue compared to the EHS group, suggesting improved exercise tolerance.

Limitations and Future Work

  • Light Microscopy Limitation: The study acknowledges that light microscopy was used for histological analysis, which may not be sensitive enough to accurately detect glomerular injury. More advanced imaging techniques could provide a deeper understanding of the injury patterns.
  • Sex Specificity: The study was conducted solely on male rats. Given that exertional heatstroke is reported in both sexes, future research should investigate whether women exhibit similar responses to ORS III pretreatment.
  • Clinical Trials Needed: The authors strongly recommend clinical trials to test the efficacy of ORS III in preventing AKI or mitigating CKD progression in humans, particularly in individuals at risk of heat stress.
  • Mechanism Exploration: While the study demonstrates the renoprotective effect of ORS III, further research is needed to fully elucidate the specific molecular mechanisms by which ORS III exerts its protective effects.

Summary updated

Abstract

ORS III could alleviate the kidney injury in EHS rats.
BibTeX
@inproceedings{lin2019renoprotective,
  author = {Yu-Fang Lin and Yanning Zhang},
  title = {{Renoprotective effect of oral rehydration solution III in exertional heatstroke rats}},
  booktitle = {Renal},
  year = {2019},
  doi = {10.1080/0886022x.2019.1590211},
}
Figure